Table 1.
Baseline Patient Demographics and Disease Characteristics of the Efficacy Population (n = 38)
| Demographic or Disease Characteristics | Value |
|---|---|
| Age, y | |
| Median | 63 |
| Range | 44–84 |
| Sex, % (n) | |
| Female | 13 (34.2) |
| Male | 25 (65.8) |
| ECOG PS, n (%) | |
| 0 | 11 (34.4) |
| 1 | 21 (65.6) |
| Missing | 6 |
| Index and nonindex lesions, n (%) | |
| Lung | 27 (71.1) |
| Lymph node | 27 (71.1) |
| Liver | 15 (39.5) |
| Bone | 3 (7.9) |
| CNS | 1 (2.6) |
| Effusion | 2 (5.3) |
| Soft tissue | 7 (18.4) |
| Other | 13 (34.2) |
| LDH (IU/L) | |
| Median | 398 |
| Range | 186–1252 |
| Missing | 4 |
| IgG (g/L) | |
| Median | 8.10 |
| Range | 0–18.00 |
| Not performed/missing | 3 |
| IgA(g/L) | |
| Median | 2.20 |
| Range | 0.70–4.20 |
| Not performed/missing | 4 |
| IgM(g/L) | 0.75 |
| Median | 0.20–2.60 |
| Range | 4 |
Note: Denominator is nonmissing data for the analysis population for each test performed.
ECOG PS, Eastern Cooperative Oncology Group performance status; CNS, central nervous system; LDH, lactate dehydrogenase; IgG, immunoglobulin G; IgA, immunoglobulin A; IgM, immunoglobulin M.